- Home
- ZSQR vs LUCD Comparison
ZSQR vs LUCD Comparison
Compare ZSQR & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZSQR | LUCD |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 192.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZSQR | LUCD |
|---|---|---|
| Price | $3.09 | $0.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 307.1K | ★ 813.2K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.27 | 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | $1,363,045.00 | ★ $4,346,000.00 |
| Revenue This Year | N/A | $115.58 |
| Revenue Next Year | N/A | $130.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $2.81 | $0.81 |
| 52 Week High | $16.62 | $1.63 |
Technical Indicators
Market Signals| Indicator | ZSQR | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 36.06 | 28.28 |
| Support Level | $2.81 | N/A |
| Resistance Level | $4.38 | $1.07 |
| Average True Range (ATR) | 0.46 | 0.05 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 20.16 | 4.77 |
Price Performance
Historical ComparisonAbout ZSQR Z Squared Inc. Common Stock
Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.